US FDA approves Scholar Rock's muscle weakness drug

The ​U.S. Food ‌and Drug ​Administration ​on Friday ⁠approved ​Scholar ​Rock's therapy to ​treat ​a rare ‌genetic ⁠condition that causes ​muscle ​weakness.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。